diabetics
Sitagliptin-Metformin Combo, Synergistically Works Against Type 2 Diabetes
Filed in archive Research , Treatment by Gloria Gamat on September 19, 2007
Metformin - commercially available as Glucophage - is a popular diabetes drug that works by making the body more responsive to insulin. On the other hand, sitagliptin or the Merck diabetes drug Januvia™ works to boost the body's ability to lower elevated blood sugar levels.

Sitagliptin-Metformin Combo, Synergistically Works Against Type 2 Diabetes



When combined together in people with type 2 diabetes, sitagliptin and metformin improves blood sugar control in a synergistic fashion, according to a new study by Merck Research Laboratories.

"This was significantly better than results with a single drug and "demonstrated an additive response."
There was a low incidence of hypoglycemia, or low blood sugar, which was not significantly different from that in the placebo group.

This study shows that the combination of sitagliptin and metformin provides "substantial and additive" improvement in blood sugar levels and is "generally well tolerated."


Find more details from Merck News.


Permalink: Sitagliptin-Metformin Combo, Synergistically Works Against Type 2 Diabetes
Tags: metformin  sitagliptin  type  2  diabetes  diabetes  drugs 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/92460
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Sitagliptin-Metformin Combo, Synergistically Works Against Type 2 Diabetes:

  • Currently 7.14/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 7.14 out of 7 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!